Elsy Boglioli Hofman
Director/Board Member at GENSIGHT BIOLOGICS S.A.
Net worth: 319 520 $ as of 2024-04-29
Profile
Ms. Elsy Boglioli Hofman is an Independent Director at FTI Consulting, Inc., a Chairman at Threefrog Therapeutics, an Independent Director at OSE Immunotherapeutics SA, an Independent Director at Gensight Biologics SA, a Chief Executive Officer at Bio-Up, an Advisor at Bluestone Venture Partners LLC and a Chief Strategy Officer & Director at Laverock Therapeutics Ltd.
She is on the Board of Directors at FTI Consulting, Inc., Wolf-Medizintechnik GmbH, Inova Software SA, OSE Immunotherapeutics SA, Gensight Biologics SA, METAFORA Biosystems SAS and Laverock Therapeutics Ltd.
Ms. Boglioli Hofman was previously employed as a Chief Operating Officer by Cellectis SA and a Managing Director & Partner by Boston Consulting Group SAS.
She received her undergraduate degree from Ecole Polytechnique and a graduate degree from Universitat Pompeu Fabra.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FTI CONSULTING, INC.
0.00% | 2024-04-06 | 1,484 ( 0.00% ) | 319 520 $ | 2024-04-29 |
Elsy Boglioli Hofman active positions
Companies | Position | Start |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Director/Board Member | 2020-09-30 |
OSE IMMUNOTHERAPEUTICS | Director/Board Member | 2021-06-23 |
FTI CONSULTING, INC. | Director/Board Member | 2023-04-06 |
Bio-Up | Chief Executive Officer | 2019-08-31 |
Bluestone Venture Partners LLC
Bluestone Venture Partners LLC Investment ManagersFinance BlueStone Venture Partners LLC (BlueStone Venture Partners) is a venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Tucson, Arizona. | Consultant / Advisor | 2017-11-30 |
Inova Software SA
Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Director/Board Member | 2021-06-30 |
METAFORA Biosystems SAS
METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Director/Board Member | 2020-08-31 |
Threefrog Therapeutics | Chairman | 2022-03-31 |
Wolf-Medizintechnik GmbH
Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Director/Board Member | 2022-02-28 |
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Elsy Boglioli Hofman
Companies | Position | End |
---|---|---|
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Elsy Boglioli Hofman
Universitat Pompeu Fabra | Graduate Degree |
Ecole Polytechnique | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
FTI CONSULTING, INC. | Commercial Services |
CELLECTIS S.A. | Health Technology |
GENSIGHT BIOLOGICS S.A. | Health Technology |
OSE IMMUNOTHERAPEUTICS | Health Technology |
Private companies | 8 |
---|---|
Boston Consulting Group SAS
Boston Consulting Group SAS Miscellaneous Commercial ServicesCommercial Services Boston Consulting Group SAS operates as a management consulting firm. It provides business and other consultancy services. The company is headquartered in Paris, France. | Commercial Services |
Inova Software SA
Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Technology Services |
Wolf-Medizintechnik GmbH
Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Distribution Services |
Bluestone Venture Partners LLC
Bluestone Venture Partners LLC Investment ManagersFinance BlueStone Venture Partners LLC (BlueStone Venture Partners) is a venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Tucson, Arizona. | Finance |
METAFORA Biosystems SAS
METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Health Technology |
Bio-Up | |
Threefrog Therapeutics | |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Health Technology |
- Stock Market
- Insiders
- Elsy Boglioli Hofman